Cargando…

Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia

OBJECTIVE: Postmenopausal women show a more atherogenic lipid profile and elevated cardiovascular risk compared to premenopausal women. The aim of this study was to investigate the efficacy and safety of high-dose atorvastatin on the improvement of the blood lipid profile of postmenopausal women in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Jaecheol, Yoo, Soyeon, Koh, Gwanpyo, Min, Kyung-Wan, Shin, Hyun Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Lipidology and Atherosclerosis 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379073/ https://www.ncbi.nlm.nih.gov/pubmed/32821729 http://dx.doi.org/10.12997/jla.2020.9.1.162

Ejemplares similares

Fasting and Postprandial Hyperglycemia: Their Predictors and Contributions to Overall Hyperglycemia in Korean Patients with Type 2 Diabetes
por: Moon, Jaecheol, et al.
Publicado: (2020)

Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss
por: Moon, Jaecheol, et al.
Publicado: (2020)

To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia
por: Agrawal, Deepak, et al.
Publicado: (2018)

Factors Associated with Glycemic Variability in Patients with Type 2 Diabetes: Focus on Oral Hypoglycemic Agents and Cardiovascular Risk Factors
por: Yoo, Soyeon, et al.
Publicado: (2015)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2021)

SUN-145 Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2019)

Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
por: Kong, Sung Hye, et al.
Publicado: (2017)

Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
por: Yoo, Soyeon, et al.
Publicado: (2019)

High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction
por: Gavazzoni, Mara, et al.
Publicado: (2017)

High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention
por: Lu, Changqing, et al.
Publicado: (2017)

Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes
por: Bang, Jisun, et al.
Publicado: (2023)

Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
por: Zheng, Dongdan, et al.
Publicado: (2015)

Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia
por: Zhang, Wei-Li, et al.
Publicado: (2014)

Severe Liver Injury Associated With High-Dose Atorvastatin Therapy
por: Saha, Amit, et al.
Publicado: (2021)

Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito(®)) in Korean adults with hypertension and hypercholesterolemia
por: Ihm, Sang-Hyun, et al.
Publicado: (2019)

Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
por: Kim, Ji Min, et al.
Publicado: (2016)

Letter: Triglyceride-Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study (J Obes Metab Syndr 2022;31:178-86)
por: Koh, Gwanpyo
Publicado: (2023)

Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia
por: Zheng, Dongdan, et al.
Publicado: (2017)

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
por: Paul, Friedemann, et al.
Publicado: (2008)

High‐dose atorvastatin improves vascular endothelial function in patients with leukoaraiosis
por: Xue, Jianan, et al.
Publicado: (2020)

Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
por: Kimura, Genjiro, et al.
Publicado: (2016)

Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30)
por: Kong, Sung Hye, et al.
Publicado: (2017)

Sex-related differences in single nucleotide polymorphisms associated with dyslipidemia in a Korean population
por: Lee, Gyeonghee, et al.
Publicado: (2022)

Short Stature is Associated with Increased Risk of Dyslipidemia in Korean Adolescents and Adults
por: Oh, Na-Kyung, et al.
Publicado: (2019)

2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents
por: Lim, Jung Sub, et al.
Publicado: (2020)

2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents
por: Lim, Jung Sub, et al.
Publicado: (2020)

Clinical effect of preoperative high-dose atorvastatin against no-reflow after PCI
por: Liu, Wenbo, et al.
Publicado: (2017)

Management Status of Cardiovascular Disease Risk Factors for Dyslipidemia among Korean Adults
por: Lee, Jongseok, et al.
Publicado: (2017)

Correction: Sex-related differences in single nucleotide polymorphisms associated with dyslipidemia in a Korean population
por: Lee, Gyeonghee, et al.
Publicado: (2022)

Efficacy and Safety of Atorvastatin in South Asian Patients with Dyslipidemia: An Open Label Noncomparative Pilot Study
por: Patel, Jeetesh V, et al.
Publicado: (2005)

Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function
por: Song, Xianbing, et al.
Publicado: (2014)

EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
por: Naydenov Naydenov, Stefan, et al.
Publicado: (2018)

Interaction and potential mechanisms between atorvastatin and voriconazole, agents used to treat dyslipidemia and fungal infections
por: Xun, Tianrong, et al.
Publicado: (2023)

Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
por: Laufs, Ulrich, et al.
Publicado: (2016)

The gene-diet associations in postmenopausal women with newly diagnosed dyslipidemia
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2017)

Prevalence and Clinical Characteristics of Dyslipidemia in Koreans
por: Jeong, Jee-Sun, et al.
Publicado: (2017)

Public Awareness of Dyslipidemia Among the Korean Population: A Survey Study
por: Bae, Jae Hyun, et al.
Publicado: (2023)

Association Between the Awareness of Dyslipidemia and Health Behavior for Control of Lipid Levels Among Korean Adults with Dyslipidemia
por: Cho, In Young, et al.
Publicado: (2017)

Associations between the Genetic Heritability of Dyslipidemia and Dietary Patterns in Korean Adults Based on Sex Differences
por: Kim, Sei, et al.
Publicado: (2023)

Pharmacokinetics and Genetic Factors of Atorvastatin in Healthy Korean Subjects
por: Kim, Serim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_itd6m91eu34kgch3ma5c95385c